Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 604 GBX -0.98% Market Closed
Market Cap: 728.1m GBX

Wall Street
Price Targets

OXB Price Targets Summary
Oxford BioMedica PLC

Wall Street analysts forecast OXB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OXB is 748.97 GBX with a low forecast of 455.51 GBX and a high forecast of 1 018.5 GBX.

Lowest
Price Target
455.51 GBX
25% Downside
Average
Price Target
748.97 GBX
24% Upside
Highest
Price Target
1 018.5 GBX
69% Upside
Oxford BioMedica PLC Competitors:
Price Targets
ELDN
Eledon Pharmaceuticals Inc
410% Upside
RYTM
Rhythm Pharmaceuticals Inc
26% Upside
LGND
Ligand Pharmaceuticals Inc
27% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
66% Upside
COV
Covalon Technologies Ltd
71% Upside
EXEL
Exelixis Inc
0% Downside
301207
Hualan Biological Bacterin Inc
3% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside

Revenue
Forecast

Revenue Estimate
Oxford BioMedica PLC

For the last 13 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 4 years is 26%.

24%
Past Growth
26%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Oxford BioMedica PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OXB's stock price target?
Price Target
748.97 GBX

According to Wall Street analysts, the average 1-year price target for OXB is 748.97 GBX with a low forecast of 455.51 GBX and a high forecast of 1 018.5 GBX.

What is Oxford BioMedica PLC's Revenue forecast?
Projected CAGR
26%

For the last 13 years the compound annual growth rate for Oxford BioMedica PLC's revenue is 24%. The projected CAGR for the next 4 years is 26%.

Back to Top